Data for Metabolomics of Metabolic Risk in Patients Taking Atypical Antipsychotics (part II) (Study ST001098)
(Analysis AN001786)Values for each metabolite have been scaled by dividing by the mean across all factors Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study| Metabolite | F1 | F2 | F3 |
|---|---|---|---|
| 14:1 (n-5) | 0.6163 | 1.0146 | 1.0512 |
| 16:1 (n-7) | 0.4230 | 0.8838 | 1.0737 |
| 18:1(n-7) | 0.6121 | 1.1299 | 1.0274 |
| 18:1(n-9) | 0.6486 | 0.9751 | 1.0400 |
| 18:2 (n-6) | 0.8344 | 1.2245 | 0.9937 |
| 18:3 (n-3) | 0.3881 | 1.1714 | 1.0469 |
| 18:3 (n-6) | 0.6046 | 0.8618 | 1.0568 |
| 20:1 (n-9) | 0.6796 | 0.9350 | 1.0410 |
| 20:2 (n-6) | 0.6557 | 1.0809 | 1.0280 |
| 20:3 (n-6) | 0.5681 | 1.2291 | 1.0216 |
| 20:4 (n-6) | 0.6529 | 1.1745 | 1.0184 |
| 20:5 (n-3) | 1.9688 | 0.6781 | 0.9312 |
| 22:1 (n-9) | 1.7698 | 0.3989 | 0.9286 |
| 22:4 (n-6) | 0.6261 | 0.9688 | 1.0431 |
| 22:5 (n-3) | 0.7808 | 0.8403 | 1.0403 |
| 22:6 (n-3) | 1.1367 | 0.9411 | 0.9917 |
| 24:1 (n-9) | 0.5838 | 1.2451 | 1.0182 |
Factors:
| F1 | Treatment:Non-obese control |
| F2 | Treatment:Obese control |
| F3 | Treatment:Schizophrenia dx |
